INOVIO Completes Enrollment in the Phase 1 US Trial of INO-4800 for COVID-19 DNA Vaccine; Interim Results Expected in June - PRNewswire

INOVIO Completes Enrollment in the Phase 1 US Trial of INO-4800 for COVID-19 DNA Vaccine; Interim Results Expected in June  PRNewswire

Comments

Popular posts from this blog